AmeriPharmTimes

  Environmental, Social, and Governance (ESG) Expectations  Introduction The pharmaceutical industry in the United States is under increasing scrutiny for its Environmental, Social, and Governance (ESG) practices. ESG factors are crucial for assessing the ethical impact and sustainability of business practices, influencing investment decisions, and ensuring long-term success. The expectations for ESG performance in the…

AI and Machine Learning in Drug Development  Introduction The intersection of artificial intelligence (AI) and machine learning (ML) with drug development marks a groundbreaking evolution in the pharmaceutical industry. In the USA, this synergy is not only enhancing the efficiency of drug discovery and development processes but also revolutionizing how diseases are understood and treated.…

Diversity, Equity, and Inclusion in Clinical Trials Introduction Diversity, equity, and inclusion (DEI) are increasingly recognized as critical components in clinical trials within the United States. Ensuring that clinical research reflects the diversity of the population is essential for developing effective and safe treatments for all individuals, regardless of race, ethnicity, gender, age, or socioeconomic…

                           AmeriPharmTimes Jul 2024                                                                               …